Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07434505 · ClinicalTrials.gov registry record · NA
Comparison of Iliac Crest Marrow vs. Proximal Tibia Avitus® Bone Graft
A NA study of Bone Graft, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07434505: Recruiting NA study of Bone Graft, sponsored by Mayo Clinic.
NCT07434505 is a NA study of Bone Graft that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07434505, a NA study of Bone Graft, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to provide comparative data about the Avitus product and its equivalence to other Bone Marrow Aspirate (BMA) harvesting techniques.
Primary Outcome
characterize what present cells can do
Conditions Studied
Interventions
- DEVICE Avitus Bone Harvester
Study Locations (1)
Florida
- Mayo Clinic - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07434505 shows while recruiting
NCT07434505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Bone Graft appearing as the primary indexed condition, and to 1 intervention - of which Avitus Bone Harvester is the first listed.
NCT07434505 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07434505 about?
NCT07434505 is a clinical study titled "Comparison of Iliac Crest Marrow vs. Proximal Tibia Avitus® Bone Graft". The purpose of this research is to provide comparative data about the Avitus product and its equivalence to other Bone Marrow Aspirate (BMA) harvesting techniques.
What is the current status of trial NCT07434505?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-11-06. Estimated completion is 2026-12.
What conditions does trial NCT07434505 study?
This clinical trial studies the following conditions: Bone Graft.
What interventions are being tested in trial NCT07434505?
The interventions under investigation include: Avitus Bone Harvester (DEVICE).
Who is sponsoring clinical trial NCT07434505?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07434505 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Graft
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07434505's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI